Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 7Withdrawn 3Terminated 2Recruiting 2Not yet recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Neuroma 1Head and Neck Neoplasms 1Chronic Pain 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 67Cyclophosphamide 65Gemcitabine 64toripalimab 61Paclitaxel 57Specimen Handling 55pembrolizumab 54sintilimab 53Surgical Procedures, Operative 52anlotinib 49Magnetic Resonance Spectroscopy 49Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 39camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Botulinum Toxins, Type A × Clear all
NCT07624877 2026-06-03

IN-PERI NEUROM

Ukrainian Society of Regional Anesthesia and Pain Therapy

Phase NA Not yet recruiting
100 enrolled

Neuroma, Chronic Pain

NCT06530524 2024-07-31

Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Not yet recruiting
50 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡